---
stable_id: R-HSA-9716913
display_name: ESR1 binds ESR1 antagonists
species: Homo sapiens
summary: 'Estrogen receptor alpha (ERα, NR3A1, nuclear receptor subfamily 3 group
  A member 1), encoded by the ESR1 gene, is a nuclear hormone receptor that is activated
  by the sex hormone estrogen. ESR1 can mediate the physiological development and
  function of various organ systems, including the reproductive, central nervous,
  skeletal, and cardiovascular systems (Kassem 1997). Accordingly, ESR1 is widely
  expressed throughout the body.<br><br>Antiestrogens (aka estrogen antagonists or
  estrogen blockers) are a class of drugs which prevent endogenous estrogens like
  estradiol from mediating their biological effects in the body. They act by blocking
  the estrogen receptor (selective estrogen receptor modulators (SERMs)) or inhibiting/suppressing
  estrogen production (selective estrogen receptor downregulators (SERDs)) (Kuiper
  et al. 1997, Sasson 1991, Fan et al. 2007). SERMs include tamoxifen (Wang et al.
  2004), clomifene (Kurosawa et al. 2010), bazedoxifene (Toniti et al. 2011) and raloxifene
  (Schafer et al. 1999), and a SERD drug is fulvestrant (Schmidt et al. 2003).<br><br>Bazedoxifene
  is used in the treatment of moderate to severe vasomotor symptoms associated with
  menopause and for postmenopausal osteoporosis (Genant 2011, Rossini et al. 2013).
  Fulvestrant used to treat hormone receptor (HR)-positive metastatic breast cancer
  in postmenopausal women (Lee et al. 2017, Lei et al. 2020).

  Clomiphene, is a medication used to treat infertility in women who do not ovulate,
  including those with polycystic ovary syndrome (Hughes et al. 2010). Raloxifene
  medication used to prevent and treat osteoporosis in postmenopausal women and those
  on glucocorticoids. It is also used to reduce the risk of breast cancer in those
  at high risk (Scott et al. 1999). Tamoxifen is used for the treatment of both early
  and advanced estrogen receptor-positive (ER-positive or ER+) breast cancer in pre-
  and postmenopausal women (Jordan 2021). Tamoxifen is also used for ovulation induction
  to treat infertility in women with anovulatory disorders.

  '
---

# ESR1 binds ESR1 antagonists
**Reactome ID:** [R-HSA-9716913](https://reactome.org/content/detail/R-HSA-9716913)
**Species:** Homo sapiens

## Summary

Estrogen receptor alpha (ERα, NR3A1, nuclear receptor subfamily 3 group A member 1), encoded by the ESR1 gene, is a nuclear hormone receptor that is activated by the sex hormone estrogen. ESR1 can mediate the physiological development and function of various organ systems, including the reproductive, central nervous, skeletal, and cardiovascular systems (Kassem 1997). Accordingly, ESR1 is widely expressed throughout the body.<br><br>Antiestrogens (aka estrogen antagonists or estrogen blockers) are a class of drugs which prevent endogenous estrogens like estradiol from mediating their biological effects in the body. They act by blocking the estrogen receptor (selective estrogen receptor modulators (SERMs)) or inhibiting/suppressing estrogen production (selective estrogen receptor downregulators (SERDs)) (Kuiper et al. 1997, Sasson 1991, Fan et al. 2007). SERMs include tamoxifen (Wang et al. 2004), clomifene (Kurosawa et al. 2010), bazedoxifene (Toniti et al. 2011) and raloxifene (Schafer et al. 1999), and a SERD drug is fulvestrant (Schmidt et al. 2003).<br><br>Bazedoxifene is used in the treatment of moderate to severe vasomotor symptoms associated with menopause and for postmenopausal osteoporosis (Genant 2011, Rossini et al. 2013). Fulvestrant used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women (Lee et al. 2017, Lei et al. 2020).
Clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome (Hughes et al. 2010). Raloxifene medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. It is also used to reduce the risk of breast cancer in those at high risk (Scott et al. 1999). Tamoxifen is used for the treatment of both early and advanced estrogen receptor-positive (ER-positive or ER+) breast cancer in pre- and postmenopausal women (Jordan 2021). Tamoxifen is also used for ovulation induction to treat infertility in women with anovulatory disorders.

